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ABSTRACT: Tricalcium phosphate (TCP) ceramics are used
as bone void ﬁllers because of their bioactivity and
resorbability, while their performance in bone regeneration
and material resorption vary with their physical properties
(e.g., the dimension of the crystal grain). Herein, three TCP
ceramic bone substitutes (TCP-S, TCP-M, and TCP-L) with
gradient crystal grain size (0.77 ± 0.21 μm for TCP-S, 1.21 ±
0.35 μm for TCP-M and 4.87 ± 1.90 μm for TCP-L), were
evaluated in a well-established rabbit lateral condylar defect
model (validated with sham) with respect to bone formation
and material resorption up to 26 weeks. Surface structure-
dependent bone regeneration was clearly shown after 4 weeks
implantation with TCP-S having most mineralized bone (20.2
± 3.4%), followed by TCP-M (14.0 ± 3.5%), sham (8.1 ± 4.2%), and TCP-L (6.6 ± 2.6%). Afterward, the amount of
mineralized bone was similar in all the three groups, but bone marrow and material resorption varied. After 26 weeks, TCP-S
induced most bone tissue formation (mineralized bone + bone marrow) (61.6 ± 7.8%) and underwent most material resorption
(80.1 ± 9.0%), followed by TCP-M (42.9 ± 5.2% and 61.4 ± 8.0% respectively), TCP-L (28.3 ± 5.5% and 45.6 ± 9.7%
respectively), and sham (25.7 ± 4.2%). Given the fact that the three ceramics are chemically identical, the results indicate that
the surface structure (especially, the crystal grain size) of TCP ceramics can greatly tune their bone regeneration potential and
the material resorption in rabbit condyle defect model, with the submicron surface structured TCP ceramic performing the best.
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1. INTRODUCTION
In orthopedic surgery, autograft is still the golden standard to
treat critical-sized bone defects. However, its drawbacks such
as complications and limited availability drove the develop-
ment of synthetic bone substitutes.1−3 Thanks to their
chemical similarity to the inorganic component of bone and
teeth, biocompatibility, bioactivity, and osteoconductivity,
calcium phosphate (CaP) ceramics including beta-tricalcium
phosphate (β-TCP), hydroxyapatite (HA), and biphasic
calcium phosphate (BCP) are often considered as bone
grafting materials, either alone or as autograft extenders.4−7
Despite that osteoconductive CaP ceramics could conduct
bone formation, the conductive bone is restricted to areas
nearby the host bone bed, limiting their clinical application in
the repair of critical-sized bone defects.8,9 However, a subgroup
of CaP ceramics with special physicochemical properties was
found to trigger bone formation, that is, osteoinduction, in
heterotopic sites (e.g., intramuscular or subcutaneous).10−12
When tested in the ectopic implantation models, the bone-
forming potential of CaP ceramics varied with their
physicochemical properties.13−19 For instance, bone formation
in CaP ceramics was aﬀected by the HA/TCP ratio in
intramuscular implantation models.13,14 In addition to the
chemistry, CaP ceramic-directed bone formation in ectopic
sites depended largely on physical factors (e.g., macro-
porosity,10−12 microporosity,15,16 and the dimension of surface
crystal grain17−19). In particular, without any osteogenic
additives, the reduction of the dimension of the surface crystal
grain could render CaP ceramics osteoinductive.17−19 For
example, a BCP ceramic with small crystal size and large
amount of micropores induced bone formation in muscle of
goats, while the one having larger crystal size and fewer
micropores did not.13 The importance of surface structure in
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material-driven osteoinduction was clearly shown in studies,
where TCP ceramic having submicron surface crystal grains
triggered bone formation in muscles while micron surface
structured TCP failed.17−19
Although material-driven osteoinduction is animal-depend-
ent,20 CaP ceramics with submicron surface crystals led to
ectopic bone formation in goats,13 canines,17−19 and FVB
mice.21 Meanwhile, these submicron-scaled surface structured
CaP ceramics enhanced bone regeneration in the iliac crest of
goats22 and the spine of beagles.23 Furthermore, such
osteoinductive CaP ceramics were as good as autograft and
outperformed a nonosteoinductive CaP ceramic in ovine
critical-sized iliac wing defects.24
In addition to serving as a temporary scaﬀold to facilitate
bone regeneration, an ideal bone substitute should gradually
degrade during the bone remodeling process and ultimately be
replaced by the newly formed bone.25,26 It is well-known that
resorption rate of CaP ceramics could be chemically controlled
by the means of HA/TCP ratio. β-TCP is of major interest and
is often used in clinics because of its higher resorption rate.27,28
Next to its chemistry, the resorption rate of TCP ceramic is
aﬀected by the physical properties (e.g., the dimension of the
surface architecture). For instance, functional osteoclast-like
cells could form on the TCP surfaces with submicron crystal
grains but not on those with micron scale crystal grains. As a
result, TCP ceramics with submicron crystal grains were more
resorbable as compared with their counterparts with micron-
scale grains following an intramuscular implantation.17−20
Given the fact that the crystal grain size largely impacted the
bone forming potential and resorption rate of TCP ceramic in
ectopic sites, it is assumed that the performance of such TCP
ceramics varies also in orthotopic sites. In this study, we
selected three TCP ceramics with gradient crystal grain size
and made comparisons in a well-established rabbit lateral
condylar defect model with respect to bone regeneration and
material resorption.29,30
2. MATERIALS AND METHODS
2.1. Preparation of TCP Ceramics. TCP-M (Osferion, Olympus,
1.0−3.0 mm) and TCP-L (chronOS, Synthes, 1.4−2.8 mm) were
purchased and used as received. TCP-S was prepared as previously
described elsewhere.24 In brief, phosphoric acid solution (H3PO4,
Fluka, Steinheim, Germany) was added dropwise to a calcium
hydroxide suspension (Ca(OH)2, Fluka) at a Ca/P ratio of 1.5. After
aging at room temperature for 6 weeks, the slurries were ﬁltered, and
TCP-S powder was eventually obtained after drying and grinding.
This powder was then foamed with diluted H2O2 (1% in distilled
water, Merck, Darmstadt, Germany) and a porogen (wax particles,
600−1000 μm, Merck) at 60 °C to get green bodies. TCP-S ceramic
was ﬁnally obtained by sintering the green bodies at 1050 °C for 8 h.
Irregularly shaped granules (1.0−2.0 mm) were prepared by crushing
the sintered bodies and sieving. The granules were then ultrasonically
cleaned with acetone (Fluka), 70% ethanol (Fluka) and demineralized
water, dried at 80 °C, and sterilized with gamma irradiation (dose
25−40 kGy, Isotron Netherlands B.V., Ede, The Netherlands) prior
to use.
2.2. Physicochemical Characterization. The chemistry of the
TCP ceramics was characterized by X-ray diﬀraction (XRD; Miniﬂex
II, Rigaku, Tokyo, Japan). The surface structure was evaluated with
scanning electron microscope (SEM; XL30, ESEM-FEG, Philips,
Eindhoven, The Netherlands) where 100 crystal grains were
randomly selected from 10 SEM images (5000×) and were measured
with AxioVision LE (Carl Zeiss MicroImaging, Inc., Breda, The
Netherlands). The pore size distribution in the ceramic strut and the
surface area of the ceramics were obtained with mercury intrusion (n
= 1 per material, Micromeritics Instrument Incorporation, Norcross,
GA, U.S.A.).
2.3. Protein Adsorption in Vitro. Ceramic granules (0.2 cc, n =
6) were soaked into 2 mL of medium composed of minimal essential
medium-alpha (a-MEM; Gibco, Invitrogen, U.K.) supplemented with
10% fetal bovine serum (FBS, Lonza, Germany) and 1% penicillin/
streptomycin (Gibco, Invitrogen, U.K.), and incubated at 37 °C in a
humid atmosphere with 5% CO2 for 4 days. After washing three times
with phosphate buﬀer solution (PBS, Invitrogen, Darmstadt,
Germany), 0.5 mL of 1% Triton solution was added to each sample.
Thereafter the amount of protein detached from the samples into the
Triton solution was measured with the QuantiPro BCA Assay Kit
(Pierce Biotechnology Inc., Rockford, U.S.A.) following the
manufacturer’s instructions, and absorbance was measured with a
spectrophotometer (Anthos Zenyth 3100, Anthos Labtec Instruments
GmbH, Salzburg, Austria) at 620 nm. A calibration curve was
prepared using standard FBS solutions. The amount of proteins
adsorbed onto the ceramics was then converted to the same amount
of the material (1.0 cc) and expressed as mean ± SD.
2.4. Calcium and Phosphate Ion Release. Calcium and
phosphate ion release from the ceramics was determined by placing
0.5 cc of ceramic granules (n = 3) in 100 mL of simulated
physiological saline (SPS; 0.8% NaCl, 50 mM HEPES, 0.4 mM NaN3,
37 °C, pH = 7.3) for 1, 4, and 7 days. The calcium and phosphate ion
concentrations in the SPS solution were measured with a
QuantiChrom Calcium assay kit (BioAssay Systems, Hayward,
U.S.A.) and a PhosphoWorks Colorimetric Phosphate assay kit
(AAT Bioquest, Inc., Sunnyvale, U.S.A.), respectively, following the
manufacturer’s guidelines. Absorbances were measured with the
spectrophotometer at 620 nm. The calcium and phosphate ion
concentrations were quantiﬁed respectively with the respective
standard calibration curves and expressed as mean ± SD.
2.5. Animal Experiment. A total of 36 New Zealand white
rabbits (female, 6 months, 3.5−4.5 kg) were used for this study.
Rabbits were housed separately in stainless steel cages in laboratory
animal at 20−25 °C with 50−60% humidity, and a light cycle
coinciding with daylight hours. They were acclimatized to their new
housing facilities for 2 weeks before surgery. Operations were
performed with the permission of the local animal ethic committee
(the Management Committee of Experimental Animals of Sichuan
Province, China) under general sterile conditions. All surgeries were
conducted under general anesthesia by intravenous injection of
sodium pentobarbital (30 mg kg1− body weight; Merck) in the
marginal ear vein of rabbits. One defect (Ø6 × 8 mm) was created on
each lateral condyle. In brief, a longitudinal skin incision of 3 cm was
made on the lateral femoral condyle, which was exposed following the
entire removal of the overlying periosteum. At this point, a 2.0 mm
pilot hole was generated with a drill (Ø = 2 mm) perpendicular to the
long axis of the femoral shaft, and then the pilot hole was gradually
widened with a larger drill (Ø = 6 mm) eventually creating a critical-
sized defect (Ø6 × 8 mm). Both lateral femoral condyles of each
rabbit were operated, and each defect was either randomly treated
with one of the three CaP ceramic granules until the defect was
completely ﬁlled (n = 6 per group), or was left untreated (sham, n =
6). Afterward, the muscle and skin were closed layer by layer with
sutures in a routine surgical manner.
After surgery, the animals were intramuscularly given buprenor-
phine (0.1 mg per animal, Merck) for 2 days to relieve pain and
penicillin (40 mg kg−1; Merck) for 3 consecutive days to prevent
infection. Animals were fed ad libitum and were allowed to move
inside their cages without restriction. At each postoperative time
interval (i.e., 4, 12, and 26 weeks after implantation), 12 rabbits were
sacriﬁced with a marginal ear vein injection of excessive amount of
sodium pentobarbital, and samples were harvested for the radio-
graphic analysis and histological evaluation.
2.6. Radiographic Examination. After stripping away the soft
tissues, the femoral condyles were ﬁxed in formaldehyde solution for 3
days, and then the bone defects were evaluated with X-ray
radiography in the sagittal plane by three people in a blinded fashion.
The conclusions were drawn on the basis of the gray level diﬀerences
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between ceramic and bone tissue, and the consequent change of gray
level distribution in the defects with implantation time.
2.7. Histological Evaluation. After radiographic examination, all
explants were trimmed as much as possible without harming the host
bone surrounding the implants and embedded in methyl methacrylate
(MMA) after dehydration with a series of ethanol solutions. The
embedded samples were trimmed and mounted on a diamond saw
microtome (Leica SP-1600, Wetzlar, Germany). Three nondecalciﬁed
sections (10−20 μm) were made crossing the middle of each explants
(on the axial plane) and stained with 1% methylene blue (Sigma-
Aldrich, St, Louis, MO) and 0.3% basic fuchsin (Sigma-Aldrich) for
light microscope observation. All the stained sections were digitalized
with a scanner (Dimage Scan Elite5400 II, Konica Minolta, Tokyo,
Japan) to obtain overview images for the quantiﬁcation of the de novo
bone formation and material resorption. The analysis was performed
by pseudocoloring pixels representing mineralized bone (MB), bone
marrow (BM), soft tissue (ST), and the remaining material (Me) in
the region of interest (ROI, a 5 × 5 mm square overlapping the center
of the defect) using Adobe Photoshop software (CS5, v12, Adobe
Systems Benelux BV, Amsterdam-Zuidoost, The Netherlands). The
Me%, MB%, BM%, bone tissue%, and ST% were calculated as follows:
Me% Me 100/ROI= ×
MB% MB 100/ROI= ×
BM% BM 100/ROI= ×
bone tissue% MB% BM%= +
ST% (ROI Me bone tissue) 100/ROI= − − ×
The ST includes ﬁbrous tissues as well as blood vessels.
The resorption rate of the ceramics was calculated as (Mi% − Me
%) × 100/Mi%, where the initial area percentage of the ceramic
material (Mi%) in the implants was determined after making 10−20
μm thick sections (ROI, a 5 × 5 mm) of MMA-embedded
nonimplanted ceramic granules (0.2−0.3 mL, n = 6).
2.8. Statistical Analysis. Statistical analysis was carried out using
one-way analysis of variance (ANOVA) with Tukey’s test (p < 0.05
for statistically signiﬁcant diﬀerences), while normality of the data was
assessed using the Shapiro-Wilk test (p > 0.05 for normally distributed
data). The power of all experiments was determined with a posthoc
statistical power analysis (one-way omnibus ANOVA test with ﬁxed
eﬀects).
3. RESULTS
3.1. Physicochemical Properties of the TCP Ceramics.
The XRD patterns of the CaP ceramics are given in Figure 1A,
which shows that the three CaP ceramics are chemically
equivalent and belong to β-TCP. SEM images showed that the
three CaP ceramics had gradient crystal grain size as expected
(Figure 1B), with crystal grain size of 0.77 ± 0.21 μm for TCP-
S, 1.21 ± 0.35 μm for TCP-M and 4.87 ± 1.90 μm for TCP-L
(Table 1). The microporosity was aﬀected by both the number
and the size of micropores and varied with materials (Figure
1B, Table 1). TCP-M had slightly higher strut porosity
(51.90%) compared with TCP-S (45.14%), while TCP-L had
the lowest strut porosity (31.52%). As also shown in Figure
1C, the micropores were mainly 0.3−1.0 μm in size for TCP-S,
0.5−1.5 μm for TCP-M and 0.5−7.0 μm for TCP-L. TCP-S
also had the highest speciﬁc surface area by volume (1.62 m2
Figure 1. (A) XRD pattern showing that the chemistry of the three TCP ceramics is β-TCP; (B) SEM images show that the three TCP ceramics
have diﬀerent surface crystal grain size; (C) Distribution plots of the surface pore dimension.
Table 1. Physicochemical Properties of CaP Ceramics
materials suppliers chemistrya
particle
size (mm)
strut pore
sizeb
surface grain
sizec (μm)
strut
porosityb
(%)
speciﬁc surface area (by
weight)b (m2 g−1)
speciﬁc surface area (by
volume)b (m2 mL−1)
TCP-S homemade β-TCP 1.0−2.0 submicron 0.77 ± 0.21 45.14 1.87 1.62
TCP-M
(Osferion)
Olympus β-TCP 1.0−3.0 submicron 1.21 ± 0.35 51.90 1.47 1.28
TCP-L
(chronOS)
Synthes β-TCP 1.4−2.8 micron 4.87 ± 1.90 31.52 0.51 0.59
aas evaluated by X-ray diﬀractometry. bobtained from mercury intrusion. cas conﬁrmed by quantitative measurements on scanning microscopic
images (5000×).
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mL−1) followed by TCP-M (1.28 m2 mL−1) and TCP-L (0.59
m2 mL−1) (Table 1).
3.2. Protein Adsorption in Vitro. After the ceramics were
soaked in culture medium containing FBS for 4 days, the
amount of protein adsorption by CaP ceramics was correlated
to their speciﬁc surface area (Figure 2A and Table 1). TCP-S
with the largest speciﬁc surface area adsorbed signiﬁcantly
more protein (183.9 ± 21.7 μg mL−1), followed by TCP-M
(137.3 ± 15.7 μg mL−1) and TCP-L (67.1 ± 10.4 μg mL−1).
3.3. Calcium and Phosphate Ion Release. The amount
of calcium ions released by the three CaP ceramics is shown in
Figure 2B. TCP-S released the most calcium ions into SPS 7.3
solution (155.1 ± 9.2 μM, 163.3 ± 12.2 μM and 166.6 ± 10.3
μM at 1, 4, and 7 days, respectively), followed by TCP-M
(130.1 ± 5.7 μM, 135.8 ± 8.8 μM and 135.7 ± 6.8 μM at 1, 4,
and 7 days, respectively) and TCP-L (79.6 ± 7.4 μM, 91.5 ±
8.3 μM, and 88.9 ± 5.9 μM at 1, 4, and 7 days, respectively).
Similarly, as shown in Figure 2C, TCP-S also released the most
phosphate ions into SPS 7.3 solution, followed by TCP-M and
TCP-L. Diﬀerences among materials were statistically sig-
niﬁcant at all end points; however, ion release did not increase
with soaking time.
3.4. Radiographic Examination. As shown in the X-ray
images (Figure 3), 4 weeks after implantation the three
materials were observed in the defects because of their higher
radiologic density compared to the adjacent cancellous bone.
In particular, the margins between the adjacent bone and the
defects ﬁlled with TCP-S and TCP-M were already indistinct,
indicating that the implanted materials were well incorporated
with the surrounding bone. On the contrary, the margin of the
sham and defects treated with TCP-L were still clearly visible,
indicating no closure. At 12 weeks, the contour of all the
Figure 2. (A) Amount of protein adsorbed into implants (1 mL) from basic medium after 4-day incubation; (B,C) Calcium and phosphate ions
release from the materials into SPS at day 1, day 4, and day 7 (stars indicate a statistically signiﬁcant diﬀerence, p < 0.05). For all the three
experiments, the Shapiro−Wilk normality test gave p > 0.05. The power (and eﬀect size) were 1.00 (2.95), 1.00 (3.74), and 0.99 (1.74) for protein
adsorption, calcium and phosphate ion release experiments, respectively.
Figure 3. X-ray photos of the rabbit condylar defects with TCP-S,
TCP-M TCP-L and sham ranging from 4 to 26 weeks postoperatively.
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implanted materials became vaguer and most likely was
continuously replaced by de novo bone; meanwhile, the
defects treated with sham were still not fully closed. At 26
weeks, the TCP-S implants almost disappeared, and the defects
had similar gray levels to the cancellous bone, followed by
TCP-M. Indeed, the resorption and material replacement with
bone in TCP-L was markedly delayed as the material was still
clearly recognized in the defects. A partial closure of sham
defects was visible.
3.5. Histological Evaluation in Summary. As shown in
the histological overviews after 4 weeks (Figure 4), a
considerable creeping MB had been penetrated well into the
whole defects treated with TCP-S, and relatively less MB was
observed at the defect margins in TCP-M implants. In defects
ﬁlled with TCP-L, limited MB was restricted to peripheral
regions close to the host bone bed, and no bone tissue could
be observed in the center of the defects. In addition, the
ceramic material within the defects was still largely intact in all
three materials.
After 12 weeks, the bone tissue (consisting of MB and BM)
increased continuously within the defects treated with all three
ceramics. The MB increased within defects implanted with
TCP-M and TCP-L, but was signiﬁcantly decreased in those
treated with TCP-S (where much MB was remodeled into
BM). Meanwhile, the amount of the residual materials
decreased as compared with the earlier end point. In addition,
the condyle defects treated with TCP-S were closed by the
newly formed bone (6/6), while those treated with TCP-M,
TCP-L, and sham were partially repaired, and no full repair
was achieved in any of the defects.
By 26-week postoperatively, de novo bone formation, bone
remodeling, and material resorption were continuously
proceeding within the defects containing ceramics. An increase
of MB was noted in condyle defects with TCP-L. Bone
remodeling primarily dominated with the evidence of
decreased MB and increased BM in those defects treated
with TCP-S and TCP-M. A limited amount of resident ceramic
was observed in the center of the defects ﬁlled with TCP-S,
while more was seen in the TCP-M group. The TCP-L
material was still predominantly present in the defects. In
addition, defects treated with TCP-M were now completely
closed with new bone (6/6), but defects treated with TCP-L
and sham were still open (6/6).
3.6. Histological Evaluation in Detail. Examination with
light microscopy revealed the presence of normal bony
structures with osteocytes embedded in the lacunae and
osteoblasts lining de novo bone after 4 weeks of treatment in
all three groups. However, BM was detected only in TCP-S,
while the space in defects treated with TCP-M and TCP-L was
generally occupied by loose connective tissue. Additionally,
numerous phagocytic cells colonized the surface of TCP-S and
phagocytized ceramic debris. Limited phagocytes adhered on
TCP-M surfaces and was rarely noted on TCP-L surfaces;
additionally, the sham consisted of much soft tissue and limited
MB (Figure 5).
After 12 weeks of implantation, the bone regeneration and
remodeling continuously proceeded with the evidence of BM
increase in TCP-S and TCP-M, and MB increase in TCP-L
(Figure 5). Meanwhile, higher phagocytic activity in TCP-S
than in TCP-M and TCP-L was seen as phagocytes engulfed
particles, and there was scalloped structure formation on the
ceramic surfaces.
After 26 weeks of implantation, MB was remodeling into
cancellous bone, BM was seen in all three implants as well as in
sham, and osteoblast-like cells were rarely seen in the center.
When such cells were seen, they were much ﬂatter than those
at 12 weeks. In addition, the number of phagocytes attached
on the TCP-S and TCP-M surface decreased compared with
those seen at the 12-week end point, while the phagocytes
were still rarely seen on TCP-L.
3.7. Quantitative Histology. At the 4-week postoperative
time interval, most MB were noted in defects treated with
TCP-S (20.2 ± 3.4%) and followed by TCP-M (14.0 ± 3.5%),
sham (8.1 ± 4.2%), and TCP-L (6.6 ± 2.6%). By 26 week
postsurgery, TCP-S gave rise to most bone tissue formation
(61.6 ± 7.8%), followed by TCP-M (42.9 ± 5.2%) and TCP-L
(28.3 ± 5.5%) and sham (25.7 ± 4.2%). Quantiﬁcation of the
absolute percentage of ceramic residuals within the defect
showed that the most resorption occurred in TCP-S (80.1 ±
9.0%), followed by TCP-M (61.4 ± 8.0%) and TCP-L (45.6 ±
Figure 4. Histological overviews showing the bone regeneration and
material resorption within condylar defects of rabbits ranging from 4
to 26 weeks postoperatively (undecalciﬁed sections stained with
methylene blue and basic fuchsin, where bone was stained fresh-red).
Figure 5. Light microscope images taken in the central of the defects
showing bone formation, bone remodeling, and degradation of CaP
ceramics implanted in condylar defects of rabbits ranging from 4 to 26
weeks postoperatively (undecalciﬁed sections stained with methylene
blue and basic fuchsin, B: bone; O: osteoid; M: material; BM: bone
marrow; ST: soft tissue; red arrows: osteoblasts; white arrows:
osteocytes; red asterisks: phagocytic cells; white asterisks: scalloped
structures of ceramics).
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9.7%) (Figure 6). Diﬀerences in total bone tissue between
materials were always statically signiﬁcant at all end points.
4. DISCUSSION
This study aimed at evaluating the bone regeneration and
material resorption as a function of crystal grain size of TCP
ceramics in a well-established rabbit lateral condylar defect
model. The main ﬁnding was that the three TCP ceramics had
diﬀerent bone regeneration potential and underwent resorp-
tion at diﬀerent rates according to the crystal grain size.
4.1. Bone Regeneration. Although each had diﬀerent
rates, the newly formed bone tissue increased with the
implantation time for all the three TCP ceramics. As shown
in Figure 4, the most de novo MB occurred throughout TCP-S
implants at 4-week postoperative time interval, followed by
TCP-M and TCP-L where limited MB was restricted in
peripheral areas adjacent to the host bone. Afterward, the
amount of MB was comparable in the three groups, but the
BM, which indicates ongoing bone remodeling, varied among
the three implanted materials (TCP-S > TCP-M > TCP-L),
resulting in a direct relationship between bone tissue (BM
+MB) and the crystal grain size. Bone regeneration in osseous
sites could be formed both by inducible mesenchymal stem
cells via osteoinduction and by osteogenic cells via
osteoconduction. In our previous study, following intra-
muscular implantation in beagles, TCP-S could induce
signiﬁcantly more ectopic bone formation (21%) than TCP-
M (8%), while TCP-L with micron scaled surface did not
trigger any bone formation.19 Therefore, the enhanced bone
regeneration and remodeling in TCP-S implants should be the
result of both the enhanced conductive bone formation in
regions close to the host bone and the inductive bone
formation in the central area of the implants.17−19,23
Indeed, it has been shown that a speciﬁc surface topography,
which occurred as a result of the combination of diﬀerent
dimensions of crystal grains and micropores with the
microporosity, could tune adherent cell fate through
mechanotransduction.19,21,31−34 More speciﬁcally, the surface
structure with a range from nano- to microscale could
profoundly inﬂuence the cellular orientation, attachment,
proliferation, and diﬀerentiation irrespectively of the chemistry,
even without osteogenic additives.33−41 In the current study,
TCP-S with crystal grains and micropores at the submicron
scale constructed a speciﬁc surface topography, which directly
aﬀected the osteogenic diﬀerentiation of inducible mesen-
chymal stem cells (osteoinduction) and the osteogenesis of
bone forming cells (osteoconduction) in orthopedic sites. As a
result, bone regeneration in condyle defects treated with TCP-
S was enhanced. This conclusion is also supported by our
previous work, where TCP-S was osteoinductive in an ectopic
site19,23 and enhanced bone regeneration in the spine.23
In addition to the surface topography, the increase of
microporosity and the concomitant decrease of crystal grain
and micropore dimensions augmented the surface area of CaP
ceramics. The enlarged surface area of TCP-S could have
entrapped and concentrated more proteins (e.g., BMP) than
TCP-M and TCP-L, which could have later induced the
diﬀerentiation of undiﬀerentiated cells to achieve osteogenesis
favoring bone formation.41−44 At the same time, calcium and
phosphate ion release was related to the physical properties of
the ceramics (e.g., surface area and crystallinity). Thus, the
enlarged surface area of TCP-S could have provided a richer
calcium ion microenvironment, which is not only a source for
the building blocks of bone but could also enhance the
proliferation, osteogenic diﬀerentiation, and mineralization of
bone-forming cells to ﬁnally synthesize bone matrix.45,46
Conversely, TCP-L with the largest crystal grains and lowest
microporosity had the least surface area and formed the least
bone. It appeared that the inﬂuence of crystal grain size on the
bone forming potential of CaP ceramics could be attributed to
the surface area that tunes protein adsorption and ion release.
Among the factors aﬀecting bone regeneration with CaP
ceramics, the size and interconnectivity of macropores (pores
>50 μm) are important ones.10−12 The macropores inside the
individual particles were interconnected, as evidenced by the
presence of inﬁltrated tissues in the pores (Figure 5). Because
the three materials studied here had similar particle size range
(1.0−3.0 mm, Table 1), they could have similar macroporosity
and fully connected microporous structures after being packed
in the defects. Therefore, the inﬂuence of pores larger than 50
μm on bone formation between the three groups could be
minimized in this study.
Figure 6. Quantitative histomorphometry data on (A) the area percentage of mineralized bone, bone marrow, other soft tissue and residual
material in ROI, and (B) the material resorption rate ranging from 4 to 26 weeks postoperatively (stars indicate a statistically signiﬁcant diﬀerence,
p < 0.05). For all three experiments, the Shapiro−Wilk normality test gave p > 0.05. The power (and eﬀect size) were 1.00 (3.90) and 1.00 (3.62)
for bone tissue and resorption experiments, respectively.
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4.2. Material Resorption. Similarly to ectopic implanta-
tion model, the resorption of TCP ceramics varied with the
crystal grain size in osseous site. The ﬁner the crystal grains,
the faster resorption was seen. TCP-S had the highest rate of
resorption, followed by TCP-M and TCP-L (Figure 6B).
The resorption of CaP ceramics was suggested to involve
two types of processes: solution-mediated disintegration (i.e.,
passive dissolution) and cell-mediated resorption.47,48 It has
been suggested that increasing the surface area could enhance
the contact between the ceramic and the surrounding body
ﬂuids rendering the material more prone to passive
dissolution.23 As shown in Figure 2B, TCP-S released the
most calcium ions indicating that it dissolved faster than TCP-
M and TCP-L due to its larger surface area (Table 1). In
addition, cell-mediated resorption has been proven to play
important roles in the resorption of CaP ceramics in vivo,
where typical osteoclastic resorption pits on CaP ceramic
surface were observed.49 As shown in detailed histological
images at the 12-week time period, a number of multinucleated
osteoclast-like cells colonized the surface of TCP-S phagocytiz-
ing material fragments and scalloping much surface (Figures
5), which indicates an active cell-mediated material resorption.
A limited amount such phagocytes and scalloped structure
surface were detected in TCP-M. Conversely, such resorbing
cells were missing in TCP-L implants (Figure 6B). Indeed, it
has been shown that the surface structure dimension greatly
aﬀected the cell-mediated resorption of TCP ceramics, via the
diﬀerential formation of multinucleated osteoclast-like cells
and resorption capacity of osteoclasts. For example, TCP with
a submicron-scale surface structure not only enhanced the
formation of osteoclasts from mononuclear cells, but it was
also resorbed by the osteoclasts formed on the surface, as
compared with its micron-scale surface structured counter-
part.50 In this study, having a larger surface area facilitating
chemical dissolution and the right surface structure, which is
suitable for the formation and function of osteoclasts, and the
submicron surface structure may have enhanced the resorption
of TCP-S ceramic.
4.3. Bone Remodeling and Material Resorption.When
comparing the bone regeneration and material resorption, the
resorption of the three TCP ceramics in osseous sites appeared
to be coupled with bone remodeling. Bone tissue consisting of
MB plus BM increased with time, ranging from 4 to 26 weeks
poste-operatively, in all the three groups (Figure 6A). The
mineralized bone in TCP-S reached its peak at week 4 and
decreased thereafter with no signiﬁcant diﬀerence to TCP-M
and TCP-L at week 12 and week 26. However, at week 12 and
26, signiﬁcantly more BM was formed in TCP-S than in TCP-
M and TCP-L. This result is in line with that previously
demonstrated,13,14,17,24 as TCP-S with the speciﬁc surface
architecture enhanced the formation of osteoclasts. This fact
not only enhanced the material resorption, but it also
facilitated the remodeling of the bone formed at the early
end points. Thus, more bone marrow could be detected in
TCP-S, while TCP-L with micron-scale surface structure did
not favor osteoclast generation and underwent the less material
resorption and bone remodeling. The group of TCP-M has a
performance between TCP-S and TCP-L.
The results obtained in this study demonstrate that, despite
the same chemical composition, the bone regeneration
capacity and resorption of CaP ceramics were diﬀerent.
Physical properties, especially the crystal grain size, are
important in determining the functionality of CaP ceramics
in bone regeneration and remodeling, and in material
resorption in rabbit condyle defect model.
These ﬁnding may provide scientists clues for further
optimization of CaP ceramic bone substitutes and would be
helpful for clinicians in selecting the right CaP ceramic bone
substitutes for bone regeneration. However, studies with larger
critical-size defects (e.g., iliac crest defect Ø = 17 mm) and
functional studies (e.g., posterolateral lumbar fusion) would be
necessary to further conﬁrm the function of submicron-scale
surface structured calcium phosphate ceramics.
5. CONCLUSIONS
When three TCP ceramics with various dimensions of crystal
grains were compared in rabbit femoral condyle defects for up
to 26 weeks, the inﬂuence of surface structure scale on bone
regeneration and material resorption was shown. Submicron
structured TCP-S gave rise to most bone formation and
underwent most resorption as compared to TCP ceramics with
larger crystal grains. The data could be useful for further
optimizing CaP ceramic bone substitutes and selecting the
most suitable CaP ceramic bone substitutes for clinical
application.
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